PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT

Salas, MQ; Charry, P; Pedraza, A; Martinez-Cibrian, N; Solano, MT; Domenech, A; Suarez-Lledo, M; Nomdedeu, M; Cid, J; Lozano, M; de-LLobet, N; Arcarons, J; Rosinol, L; Gutierrez-Garcia, G; Carreras, E; Esteve, J; Urbano-Ispizua, A; Fernandez-Aviles, F; Rovira, M; Martinez, C

Salas, MQ (通讯作者)，Hosp Clin Barcelona, Clin Inst Hematol & Oncol ICMHO, Hematol Dept, Hematopoiet Transplantat Unit, C Vilarroel 190, Barcelona 08036, Spain.

TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (8):

Abstract

The use of post-transplantation cyclophosphamide (PTCY) for graft-versus-host disease (GHVD) prevention is becoming prevalent in the transplantation c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索